Cliantha Research acquires Inflamax Research
With the new acquisition, Cliantha Research will have the capabilities to perform Phase I, II, III and IV clinical research in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Avantor acquires Puritan products
Acquisition bolsters Avantor’s portfolio of high-purity cGMP materials and solutions for Biopharma, Research, and Electronic…
Aurobindo Pharma gets six observations from US FDA for Hyderabad unit
US FDA had conducted an inspection at the company’s Unit III, a formulations manufacturing facility at Bachupally, Hyderabad
IPR Building Block or Stumbling Block?
With World Intellectual Property Day round the corner, Express Pharma explores the evolving IPR scenario in India and its impact…
Patent system, only way to promote innovation?
Yogesh Pai, Assistant Professor of Law and Co-Director of the Centre for Innovation, Intellectual Property and Competition (CIIPC)…
A balancing act
Ashish Prasad, Partner, Economic Laws Practice Delhi, analyses IPR in India, elaborates on the need to evolve an effective IPR…
Techniques to enhance IP valuations
Dr Gopakumar G Nair, CEO, Gopakumar Nair Associates, gives an insight on why IP systems must support innovations by creating a…
On the right track
Ashwin Sapra, Partner, and Biplab Lenin, Consultant, Cyril Amarchand Mangaldas, give an insight on how adequate research and…
Hedging against uncertainty in the IPR Regime: Contractual protections
Anay Shukla, Lead, Pharma Healthcare team, Darren Punnen, Member, Pharma Healthcare team and Vidya Phanse, Intern, Nishith Desai…
The Bt cotton saga
Rajeev Kumar, Partner, LexOrbis provides a commentary on the facts and questions of law that are raised in the current Bt. cotton…